Found: 3
Select item for more details and to access through your institution.
Spleen tyrosine kinase ( SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients.
- Published in:
- Experimental Dermatology, 2016, v. 25, n. 5, p. 375, doi. 10.1111/exd.12986
- By:
- Publication type:
- Article
Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 1, p. 1, doi. 10.1371/journal.pntd.0006116
- By:
- Publication type:
- Article
IL-36γ (IL-1F9) Is a Biomarker for Psoriasis Skin Lesions.
- Published in:
- Journal of Investigative Dermatology, 2015, v. 135, n. 4, p. 1025, doi. 10.1038/jid.2014.532
- By:
- Publication type:
- Article